FDA on Avandia Restrictions
Health Officials Consider Avandia Restrictions. The knell appeared to sound for Avandia a few years ago when federal health officials decided to almost ban the drug outright because it had been linked to myriad health problems. Today, the U.S. Food and Drug Administration (FDA) is appearing to go back on those restrictions as the … [Read more...]
Calls for Significant Gilenya Restrictions
A Safety Group Calls For Gilenya Restriction. A patient safety group believes access to the multiple sclerosis drug Gilenya should be severely restricted because its short time on the market has been plagued by reports of fatal adverse reactions. According to a report at Pharmalot.com, the Institute for Safe Medicine … [Read more...]
Use of Multaq Should be Curbed
Multaq Safety Issues. Multaq safety worries have prompted regulators to issue new restrictions for the drug. According to a report from The Wall Street Journal, concerns about Multaq's impact on the heart, lungs and liver might soon prompt the U.S. Food & Drug Administration (FDA) to take similar steps in the … [Read more...]
GlaxoSmithKline Outlook Falls
GlaxoSmithKline Outlook Falls. GlaxoSmithKline’s Avandia problems are expected to take a toll on the drug maker’s bottom line. According to a Reuters report, analysts have already begun cutting Glaxo’s earnings forecast, after regulators in the US and Europe announced separate actions that will likely scuttle Avandia’s … [Read more...]
Senate Panel Looking at Medical Devices Consumer Ads
Medical Devices Misleading Ads. Some lawmakers, medical groups, and others are seeking restrictions on some direct-to-consumer advertisements for medical devices such as artificial knees and heart stents, claiming such ads mislead patients. The amount of medical device advertising directed to consumers on television or over the … [Read more...]
Avelox, Similar Antibiotics Face European Restrictions Due to Liver Damage
Avelox European Restrictions Due to Liver Damage. Restrictions Due to Liver Damage Moxifloxicin, a fluoroquinolone antibiotic sold as Avelox by Bayer, is being subjected to new warnings and restrictions by the European Medicines Agency (EMA) because of its association with adverse liver reactions. Moxifloxacin is used to … [Read more...]
Tough Toy Safety Bill in Washington State Has Manufacturers Worried
Washington Lawmakers Passed A Tough Toy Safety Bill. Washington state lawmakers overwhelmingly passed a toy safety bill setting the toughest restrictions in the nation on the lead content of children's products. If passed, the bill would reduce the allowable level of lead in toys and other goods to 90 parts per … [Read more...]
